Comparing the efficacy and quality of life of vildagliptin + metformin and sulfonylureas + metformin in patients with type 2 diabetes mellitus
Phase of Trial: Phase II
Latest Information Update: 02 Nov 2016
Price : $35 *
At a glance
- Drugs Vildagliptin (Primary) ; Metformin; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 02 Nov 2016 Results presented at the 19th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research.
- 06 Dec 2013 New trial record
- 06 Nov 2013 Results presented at the 16th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes Research.